NKX2-5 and coronary artery disorder: hPSCs derived from individuals harboring CHD-associated mutations (e.g., in NKX2-5 or TBX1) can be differentiated into cardiac organoids that manifest disease-relevant phenotypes, such as impaired septation, altered electrophysiology, or reduced cardiomyocyte proliferation (Hofbauer et al., 2021).